Breast Surgery

Breast Implant Illness: What We Actually Know

A patient community reports a consistent cluster of symptoms. The evidence is complicated. Here's what's supported, what's contested, and what to consider.

Breast implant illness (BII) is a term used by a large patient community to describe a cluster of systemic symptoms attributed to breast implants. The symptoms most commonly reported are fatigue, brain fog, joint pain, muscle aches, hair loss, rashes, anxiety, digestive changes, and a general "not feeling well" that doesn't map cleanly to any single medical diagnosis. Many patients report improvement after implant removal.

BII is not currently a recognized medical diagnosis in the sense that most physicians use that term — there's no single confirmatory test, no ICD code specific to it, and no established mechanism proven to link implants to the reported symptoms. This has created a difficult clinical situation: a large patient community reporting consistent experiences, and a medical establishment that has been slow to develop a clear framework for evaluation and response.

This piece walks through what's supported, what's contested, and what considerations matter for anyone thinking about implants or considering explant.

What the reported symptom cluster looks like

Patient-reported BII symptoms, in rough order of reporting frequency:

Not every patient with BII reports all of these; the symptom pattern varies. Onset can be gradual (years after implantation) or more acute (following rupture, infection, or capsular contracture).

The evidence state, honestly

QuestionCurrent state of evidence
Do patients report the symptom cluster consistently?Yes — well documented across patient surveys, registries, and case series.
Is there a proven biological mechanism linking implants to systemic symptoms?Not currently. Multiple hypotheses (silicone bleed, biofilm, immune activation, heavy metal exposure) exist; none are established.
Do symptoms improve after explant?Reported yes in majority of patient-reported outcome studies. Formal controlled trials remain limited. Response is variable.
Is BII a recognized medical diagnosis?Not currently in standard diagnostic frameworks. Some medical organizations acknowledge the pattern as 'systemic symptoms associated with breast implants' or similar.
Have regulators taken action?Yes — the FDA now requires 'black box' warnings on breast implants and has issued patient decision-aid documentation. Some textured implants have been withdrawn for BIA-ALCL risk (a separate specific cancer diagnosis).
Is BIA-ALCL the same as BII?No. BIA-ALCL is a specific, rare cancer of the immune system associated with certain textured implants. It has a specific diagnostic pathway and treatment protocol. BII is a broader, less-defined symptom cluster.

What responsible clinical practice looks like around BII

The reasonable position that most careful surgeons have converged toward:

What this article cannot tell you

Whether your specific symptoms are caused by your implants. Only your own clinical evaluation with a physician who takes the concern seriously and performs appropriate testing can address that. This piece is context to help you have that conversation, not a substitute for it.

Considerations for someone thinking about first-time augmentation

For a patient considering breast augmentation who has learned about BII, the reasonable questions to ask before proceeding:

None of these questions preclude choosing augmentation. They're the informed-consent framework that responsible patients and surgeons work within together.

Considerations for someone thinking about explant

For a patient with BII-attributed symptoms considering explant:

Verification and standards for Colombia procedures

SCCP membership for the surgeon (verify in the SCCP directory). JCI-accredited hospital or equivalently accredited facility — six Colombian hospitals hold JCI. ReTHUS-registered anesthesiologist. Colombia's #1 Western Hemisphere / #22 global WHO healthcare ranking (per the 2000 World Health Report) sits behind the credentialing infrastructure. For any procedure related to implant complications or BII evaluation, the surgeon's experience with revision and explant work specifically matters — ask about volume of explant cases per year, and to see explant-specific before-and-after documentation.

Where to be careful

The BII patient community is large and often frustrated with mainstream medical dismissal, which has created space for alternative practitioners offering unproven "detox" protocols, IV therapies, "explant support" supplements, and other products that trade on the frustration without evidence. Legitimate BII care is a medical process — evaluation, technique-appropriate surgery when indicated, and evidence-based post-operative care — not a wellness product category.

Frequently asked questions

Is BII the same as BIA-ALCL?

No. BIA-ALCL is a specific, rare cancer of the immune system with an established diagnostic pathway and treatment protocol. It's been associated with certain textured implants that have been withdrawn from many markets. BII is a broader systemic symptom cluster without a specific confirmatory test or established mechanism.

What percentage of implant patients get BII?

Estimates vary widely because there's no diagnostic definition — patient survey data and clinical series report anywhere from a few percent to over 20% reporting some cluster of symptoms attributed to implants. What's clear is that it's not rare; what's not clear is the underlying mechanism or precise incidence.

How long after implant surgery can BII symptoms appear?

Reported timing varies enormously. Some patients report symptoms starting within months of implantation; some report onset years after. Some patients are asymptomatic for a decade before symptoms develop. This variability makes causation difficult to establish clinically.

Does the type of implant matter for BII?

Patient-reported outcomes suggest smooth silicone, textured silicone, and saline implants have all been associated with reported BII. Whether one type has a higher association than others is not clearly established. The textured implant / BIA-ALCL link is a separate, specific association distinct from BII.

If I explant and symptoms don't resolve, is that proof they weren't caused by implants?

Not necessarily. Some patients respond fully to explant; some respond partially; some respond minimally. Non-response doesn't disprove implant causation, and full response doesn't prove it definitively either. Individual response is variable, and the underlying biology is not yet well understood.

Ready to get a real quote? Tell us what you're considering and we'll connect you with SCCP-certified surgeons and give you a straight answer on realistic pricing.

Message us on WhatsApp →